Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Retained Earnings (2010 - 2026)

Curis' (CRIS) quarterly Retained Earnings came in at -$1.3 billion in Q2 2026, little changed on a YoY basis from -$1.3 billion in Q2 2025, and little changed quarter-over-quarter from -$1.3 billion in Q1 2026.

Analysis

Curis (CRIS) Retained Earnings (2010 - 2026) Analysis & Trends

Curis (CRIS) has reported Retained Earnings for 17 consecutive years, with -$1.3 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings changed 0.0% year-over-year to -$1.3 billion; the trailing twelve-month figure through Jun 2026 stood at -$1.3 billion (changed 0.0% YoY), and the FY2025 full-year result was -$1.2 billion, down 0.61% from the prior year.
  • Retained Earnings held at -$1.3 billion in Q2 2026 per CRIS's latest filing, from -$1.3 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at -$1.1 billion in Q1 2022 and bottomed at -$1.3 billion in Q1 2025.
  • Historically, Retained Earnings has averaged -$1.2 billion across 5 years, with a median of -$1.2 billion in 2024.
  • The sharpest annual moves came in 2023 and 2026: Retained Earnings fell 8.26% in 2023, then changed 0.0% in 2026.
  • Over 5 years, Retained Earnings stood at -$1.1 billion in 2022, then decreased by 4.13% to -$1.2 billion in 2023, then slipped by 3.63% to -$1.2 billion in 2024, then slipped by 0.61% to -$1.2 billion in 2025, then declined by 4.22% to -$1.3 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$1.3 billion, -$1.3 billion, and -$1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 Curis 2.63 Mn -2.99 Mn - -1.30 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.30 Bn
Mar 31, 2026 -1.30 Bn
Dec 31, 2025 -1.25 Bn
Sep 30, 2025 -1.30 Bn
Jun 30, 2025 -1.30 Bn
Mar 31, 2025 -1.30 Bn
Dec 31, 2024 -1.24 Bn
Sep 30, 2024 -1.23 Bn
Jun 30, 2024 -1.22 Bn
Mar 31, 2024 -1.21 Bn
Dec 31, 2023 -1.20 Bn
Sep 30, 2023 -1.20 Bn
Jun 30, 2023 -1.20 Bn
Mar 31, 2023 -1.20 Bn
Dec 31, 2022 -1.15 Bn
Sep 30, 2022 -1.14 Bn
Jun 30, 2022 -1.12 Bn
Mar 31, 2022 -1.11 Bn
Dec 31, 2021 -1.09 Bn
Sep 30, 2021 -1.10 Bn